Several novel genes that are upregulated in diabetic kidneys have been identified. Recently, transforming growth factor beta driven secreted proteins, i.e., connective tissue growth factor and gremlin (bone morphogenetic protein 2), have been identified, and their expression has been correlated with the tissue changes seen in diabetic nephropathy in the adult population. However, there are very few studies reported in the literature that describe the gene expression in the diabetic state during embryonic and neonatal life. It is well known that exposure to glucose or its epimer, i.e., mannose, induces marked dysmorphogenesis of the embryonic metanephros in an organ culture system. These changes are associated with ATP depletion and marked apoptosis, suggesting an oxidant stress in the induction of dysmorphogenesis of the embryonic metanephros. In view of the glucose-induced changes in the fetal metanephros, a diabetic state was induced by the administration of streptozotocin during pregnancy, and newborn mouse kidneys were processed for suppression subtractive hybridization-PCR. In addition, a diabetic state was induced in newborn diabetic mice, and after 1 week their kidneys were harvested and subjected to representational difference analysais of cDNA. Four novel genes with upregulated mRNA expression were identified. They included: (1) a translocase inner mitochondrial membrane 44 that is involved in the ATP-dependent import of preproteins from the cytosol into the mitochondrial matrix; (2) a kidney-specific aldo-keto reductase that utilizes NADPH and NADH as cofactors in the reduction of aromatic aldehydes and aldohexoses; (3) Rap1b, a Ras-related small GTP-binding protein that behaves as a GTPase and cycles between GTP-bound (active) and GDP-bound (inactive) states associated with conformational change, and (4) a fusion protein of ubiquitin polypeptide and ribosomal protein L40 (UbA52 or ubiquitin/60) that is intimately involved in the ubiquitin-dependent proteasome pathway related to the accelerated degradation of proteins under various stress conditions, such as those seen in patients with cancer and diabetes mellitus.

Keywords:
Diabetes mellitus, Gene expression, Renal development
1.
Molsted-Pedersen L, Tygstrup I, Pedersen J: Congenital malformation in newborn infants of diabetic women. Lancet 1964;i:1124–1126.
2.
Eriksson UL, Cederberg J, Wentzel P: Mechanisms of diabetic embryopathy. Diabetes Annu 1999;12:359–396.
3.
Potter EL: Normal and Abnormal Development of the Kidney. Chicago, Year Book Medical Publishers, 1972.
4.
Saxen L: Organogenesis of the kidney. New York, Cambridge University Press, 1987.
5.
Robert B, St John PL, Hyink DP, Abrahamson DR: Evidence that embryonic kidney cell expressing flk-1 are intrinsic, vasculogenic angioblasts. Am J Physiol 1996;40:F744–F753.
6.
Grobstein C: Trans-filter induction of tubules in mouse metanephric mesenchyme. Exp Cell Res 1956;10:424–440.
7.
Ekblom P: Renal development; in Sheldin DW, Giebisch G (eds): The Kidney. New York, Raven Press, 1992, pp 475–501.
8.
Stuart RO, Nigam SK: Developmental biology of the kidney; in Brenner BM (ed): The Kidney. Philadelphia, Saunders, 2000, pp 68–92.
9.
Kanwar YS, Carone FA, Kumar A, Wada J, Ota K, Wallner EI: Role of extracellular matrix, growth factors and proto-oncogenes in metanephric development. Kidney Int 1997;52:589–606.
10.
Liu ZZ, Carone FA, Dalecki TM, Lelongt B, Wallner EI, Kanwar YS: Mannose-induced dysmorphogenesis of metanephric kidney: Role of proteoglycans and ATP. J Clin Invest 1992;90:1205–1218.
11.
Kanwar YS, Liu ZZ, Kumar A, Usman MI, Wada J, Wallner EI: D-Glucose-induced dysmorphogenesis of embryonic kidney. J Clin Invest 1996;98:2478–2488.
12.
Kanwar YS, Liu ZZ, Wallner EI: Influence of glucose on murine metanephric development and proteoglycans: Morphologic and biochemical studies. Lab Invest 1997;76:671–681.
13.
Lee BH, Ha H, Kim S, Ziyadeh FN: Diabetic kidney disease research at the turn of the century. Kidney Int 2000;58(suppl 77):1–113.
14.
Giardino I, Brownlee M: The biochemical basis of microvascular disease; in Pickup JC, Williams G (eds): Textbook of Diabetes. London, Blackwell Sciences, 1998, pp 42.1–42.16.
15.
Parving HH, Osterby R, Ritz E: Diabetic nephropathy; in Brenner BM (ed): The Kidney. Philadelphia, Saunders, 2000, pp 1731–1773.
16.
Abrass CK, Spicer D, Berfield AK, St John PL, Abrahamson DR: Diabetes induces changes in glomerular development and laminin-β2 (s-laminin) expression. Am J Pathol 1997;151:1131–1140.
17.
Wada J, Kanwar YS: Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney. Proc Natl Acad Sci USA 1998;95:144–140.
18.
Lin S, Chugh S, Pan X, Wallner EI, Wada J, Kanwar YS: Identification of up-regulated-Ras-like GTPase, Rap1b, in diabetic newborn mice kidneys by suppression subtractive hybridization. Kidney Int, in press.
19.
Antonetti DA, Reynet C, Kahn CR: Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus. J Clin Invest 1995;95:1383–1388.
20.
Nishio Y, Warren CE, Buczek-Thomas JA, Rulfs J, Koya D, Aiello LP, Feener EP, Miller TB, Dennis JW, King GL: Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest 1995;96:1759–1767.
21.
Gerbitz KD, Gempel K, Brdiczka D: Mitochondria and diabetes: Genetic, biochemical and clinical implications of the cellular energy circuit. Diabetes 1996;45:113–126.
22.
Yang X, Borg LAB, Eriksson UJ: Altered mitochondrial morphology of rat embryos in diabetic pregnancy. Anat Rec 1995;241:255–267.
23.
Suzuki N, Svensson K, Eriksson UJ: High glucose concentration inhibits migration of rat cranial neural crest cells in vitro. Diabetologia 1996;39:401–411.
24.
Yang X, Borg LAH, Eriksson UJ: Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 1997;272:E173–E180.
25.
Sager K, Ellington E, Jez J, Ratnam K, Penning TM: AKR Superfamily Home Page (http://www.med.upenn.edu/akr/). January 18, 2000.
26.
Yabe-Nishimura C: Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacol Rev 1998;50:21–33.
27.
Yang Q, Dixit B, Wada J, Tian Y, Wallner EI, Srivastava SK, Kanwar YS: Identification of a renal-specific oxido-reductase in newborn diabetic mice. Proc Natl Acad Sci USA 2000;97:9896–9901.
28.
Takai Y, Sasaki T, Matozaki T: Small GTP-binding proteins. Physiol Rev 2001;81:153–208.
29.
Okada S, Matsuda M, Anafi M, Pawson T, Pessin JE: Insulin regulates the dynamic balance between Ras and Rap1 signaling by coordinating the assembly states of Grb2-SOS and CrkII-C3G complexes. EMBO J 1998;17:2554–2565.
30.
Bos JL: All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. EMBO J 1998;17:6776–6782.
31.
Pennington SR: G proteins and diabetes. Nature 1987;327:188–189.
32.
Kim SI, Kim HJ, Han DC, Lee HB: Effect of lovastatin on small GTP binding proteins and on TGF-β1 and fibronectin expression. Kidney Int 2000;58(suppl 77):88–92.
33.
Hershko A, Ciechanover A: The ubiquitin system. Annu Rev Biochem 1998;67:425–479.
34.
Lanley JD, Hochstrasser M: Substrate targeting in the ubiquitin system. Cell 1999;97:427–430.
35.
Glotzer MA, Murray AW, Kirschner MW: Cyclin is degraded by the ubiquitin pathway. Nature 1991;349:132–138.
36.
Mitch WE, Goldberg AE: Mechanisms of muscle wasting: The role of the ubiquitin-proteasome pathway. N Engl J Med 1996;335:1897–1905.
37.
Coux O, Tanaka K, Goldberg AL: Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996;65:801–847.
38.
Lin S, Chugh SS, Pan X, Wada J, Wuthrich RP, Kanwar YS: Cloning and characterization of 5′-flanking region of UbA52 and its renal expression in newborn diabetic mouse (abstract). J Am Soc Nephrol 2001;12:840.
39.
Nishikawa T, Edelstein D, Brownlee M: The missing link: A single unifying mechanism for diabetic complications. Kidney Int 2000;58(suppl 77):26–30.
40.
Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 2000;404:787–790.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.